| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.23 | 0.0003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |